Analysed IMMUNIC INC (IMUX:NASDAQ) News Sources
Immunic advances MS drug toward key Phase 3 data, expects results by year-end
11-08-2026
proactiveinvestors.com
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
02-09-2026
yahoo.com
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
07-10-2026
yahoo.com
What is the current price of IMMUNIC INC (IMUX:NASDAQ)?
The current price of IMMUNIC INC (IMUX:NASDAQ) is $6.89.
IMMUNIC INC (IMUX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNIC INC (IMUX:NASDAQ) since the previous trading day is $-1.06.
IMMUNIC INC (IMUX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNIC INC (IMUX:NASDAQ) since the previous trading day is -13.3333%.
What is the most recent average sentiment score for IMMUNIC INC (IMUX:NASDAQ)?
The most recent average sentiment score for IMMUNIC INC (IMUX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for IMMUNIC INC (IMUX:NASDAQ)?
The most recent sentiment for IMMUNIC INC (IMUX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNIC INC (IMUX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.